摘要
目的初步评价丹参注射液的临床应用安全性。方法调查统计粤北人民医院2008年4月—12月所有使用过丹参注射液的住院患者病例,并分析其用药情况。结果共收集使用过丹参注射液的住院患者病例968例,调查结果涉及19个科,30余种病种。发生ADR有12例,占1.2%。其中按说明书规定的适应症、用法用量使用不良反应发生率最低。结论严格按照药品说明书的规定使用有利于提高其临床应用的安全性。
OBJECTIVE To generally evaluate the clinical security of the Salvia Miltiorrhiza injection.METHODS Collect statistics and research on the inpatient cases of Salvia Miltiorrhiza injection in people＇s hospital of Yuebei during the period of April and December 2008.RESULTS Based on the 968 inpatient cases of SMI collected which involved 19 departments and 30-odd diseases,whilst ADR occurred in 12 cases（1.2% among the total）.The rate of negative-effect was utmost reduced when the applications followed the instructions of symptom,procedure and dosage.CONCLUSION The security of clinical application of SMI would be enhanced by accurate operations that are strictly in line with the instructions of treatment.
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2010年第8期753-756,共4页
Chinese Journal of Modern Applied Pharmacy
关键词
丹参注射液
临床应用
合理用药
安全性
Salvia Miltiorrhiza injection
clinical application
rational drug use
safety
